Shkreli Nightmare Not Over for Drug Companies

When asked whether she saw a difference between Shkreli and the rest of the pharmaceutical industry, Representative Rosa DeLauro, who sits on a House Democrats task force on drug pricing, gave a one-word answer: “No.”